Cardiff Lexington Corp Files 10-K/A Amendment
Ticker: CDIX · Form: 10-K/A · Filed: Aug 19, 2025 · CIK: 811222
Sentiment: neutral
Topics: amendment, annual-report, filing
TL;DR
Cardiff Lexington Corp filed an amendment to its 2024 10-K on Aug 19, 2025. Check for updates.
AI Summary
Cardiff Lexington Corporation filed an amendment (10-K/A) to its annual report on August 19, 2025, for the fiscal year ending December 31, 2024. The company, previously known as Cardiff International Inc., is based in Las Vegas, NV, and operates in the medical services sector. This filing provides updated information for the period.
Why It Matters
This amendment provides updated financial and operational information for Cardiff Lexington Corp, crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, not indicating new or significant negative developments.
Key Numbers
- 2024 — Fiscal Year (Period of Report)
- 2023 — Prior Fiscal Year (Comparative Period)
Key Players & Entities
- Cardiff Lexington Corp (company) — Filer
- August 19, 2025 (date) — Filing Date
- December 31, 2024 (date) — Fiscal Year End
- Cardiff International Inc. (company) — Former Company Name
- Las Vegas, NV (location) — Business Address
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the Form 10-K for the fiscal year ended December 31, 2024, indicating updates or corrections to previously submitted information.
When was this amendment filed?
This amendment was filed on August 19, 2025.
What was Cardiff Lexington Corp's former name?
Cardiff Lexington Corp was formerly known as Cardiff International Inc., United American Inc., and Cardiff Financial Inc.
Where is Cardiff Lexington Corp located?
The company's business and mailing address is 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169.
What is the SIC code for Cardiff Lexington Corp?
The Standard Industrial Classification code is 8011, which falls under SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE.
Filing Stats: 4,498 words · 18 min read · ~15 pages · Grade level 16 · Accepted 2025-08-19 16:11:03
Key Financial Figures
- $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value Indicate by check mark if th
Filing Documents
- cardiff_i10ka1-123124.htm (10-K/A) — 1798KB
- cardiff_ex2301.htm (EX-23.1) — 3KB
- cardiff_ex2302.htm (EX-23.2) — 2KB
- cardiff_ex3101.htm (EX-31.1) — 12KB
- cardiff_ex3102.htm (EX-31.2) — 12KB
- cardiff_ex3201.htm (EX-32.1) — 4KB
- cardiff_ex3202.htm (EX-32.2) — 4KB
- image_001.jpg (GRAPHIC) — 19KB
- image_002.jpg (GRAPHIC) — 7KB
- 0001683168-25-006321.txt ( ) — 7887KB
- cdif-20241231.xsd (EX-101.SCH) — 65KB
- cdif-20241231_cal.xml (EX-101.CAL) — 69KB
- cdif-20241231_def.xml (EX-101.DEF) — 224KB
- cdif-20241231_lab.xml (EX-101.LAB) — 398KB
- cdif-20241231_pre.xml (EX-101.PRE) — 344KB
- cardiff_i10ka1-123124_htm.xml (XML) — 1192KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations. 35 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk. 46 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data. 46 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 46 Item 9A.
Controls and Procedures
Controls and Procedures. 46 Item 9B. Other Information. 48 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 48 PART III Item 10. Directors, Executive Officers and Corporate Governance. 49 Item 11.
Executive Compensation
Executive Compensation. 54 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 59 Item 13. Certain Relationships and Related Transactions, and Director Independence. 60 Item 14. Principal Accounting Fees and Services. 61 PART IV Item 15. Exhibits and Financial Statement Schedules. 62 Item 16. Form 10-K Summary. 65 i INTRODUCTORY NOTES Use of Terms Except as otherwise indicated by the context and for the purposes of this report only, references in this report to "we," "us," "our" and "our company" are to Cardiff Lexington Corporation, a Nevada corporation, and its consolidated subsidiaries. Special Note Regarding Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management's beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our ability to successfully identify and acquire additional businesses; our ability to effectively integrate and operate the businesses that we acquire; our expectations around the performance of our current businesses; our ability to maintain our business model and improve our capital efficiency; our ability to effectively manage the growth of our business; our ability to maintain profitabi